Zobrazeno 1 - 10
of 229
pro vyhledávání: '"Fengming, Tang"'
Autor:
Ali O. Malik, Hungta Chen, Fengming Tang, Paul S. Chan, Andrew Cooper, Marίlia B. Gomes, Vittal Hejjaji, Linong Ji, Kamlesh Khunti, Mikhail Kosiborod, Antonio Nicolucci, Poghni A. Peri-Okonny, Marina V. Shestakova, Jiten Vora, Hirotaka Watada, Suzanne V. Arnold
Publikováno v:
Indian Heart Journal, Vol 74, Iss 5, Pp 398-405 (2022)
Background: We sought to describe global patterns in achievement of risk factor control for primary prevention in patients with T2D and explore the association of country's GNI/capita with risk factor control. Methods: The DISCOVER study is a prospec
Externí odkaz:
https://doaj.org/article/0b861168d8c047968765dcefd3c338f7
Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER
Autor:
Suzanne V. Arnold, Fengming Tang, Andrew Cooper, Hungta Chen, Marilia B. Gomes, Wolfgang Rathmann, Iichiro Shimomura, Jiten Vora, Hirotaka Watada, Kamlesh Khunti, Mikhail Kosiborod
Publikováno v:
BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background Despite strong evidence of benefit, uptake of newer glucose-lowering medications that reduce cardiovascular risk has been low. We sought to examine global trends and predictors of use of SGLT2i and GLP-1 RA in patients with type 2
Externí odkaz:
https://doaj.org/article/ec3b44102c7e4396b62acc311ae65d72
Publikováno v:
BMC Medical Research Methodology, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Although frequentist paradigm has been the predominant approach to clinical studies for decades, some limitations associated with the frequentist null hypothesis significance testing have been recognized. Bayesian approaches can p
Externí odkaz:
https://doaj.org/article/e009e81a679e4748911c566390d1c06a
Autor:
Suzanne V. Arnold, Kamlesh Khunti, Fabrice Bonnet, Bernard Charbonnel, Hungta Chen, Javier Cid‐Ruzafa, Andrew Cooper, Peter Fenici, Marilia B. Gomes, Niklas Hammar, Linong Ji, Gabriela Luporini‐Saraiva, Jesús Medina, Antonio Nicolucci, Larisa Ramirez, Marina V. Shestakova, Iichiro Shimomura, Filip Surmont, Fengming Tang, Jiten Vora, Hirotaka Watada, Mikhail Kosiborod, the DISCOVER investigators
Publikováno v:
ESC Heart Failure, Vol 8, Iss 2, Pp 1711-1716 (2021)
Abstract Aims Heart failure (HF) is increasingly recognized as a major cause of morbidity and mortality in patients with type 2 diabetes (T2D), but the global epidemiology and treatment of HF in T2D are not well defined. This study aimed to examine t
Externí odkaz:
https://doaj.org/article/6f0d5cf6e07a4fcc98c4a0e71fee4e3d
Autor:
Marília B. Gomes, Fengming Tang, Hungta Chen, Javier Cid-Ruzafa, Peter Fenici, Kamlesh Khunti, Wolfgang Rathmann, Marina V. Shestakova, Filip Surmont, Hirotaka Watada, Jesús Medina, Iichiro Shimomura, Gabriela Luporini Saraiva, Andrew Cooper, Antonio Nicolucci
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
DISCOVER is a 3-year observational study program of 15,983 people with type 2 diabetes initiating second-line glucose-lowering therapy in 38 countries. We investigated the association between socioeconomic status and both the availability of a baseli
Externí odkaz:
https://doaj.org/article/6c2277abaa80486181f4c6426ca2717c
Autor:
Suzanne V. Arnold, Kamlesh Khunti, Fengming Tang, Hungta Chen, Antonio Nicolucci, Marilia B. Gomes, Linong Ji, Marina V. Shestakova, Hirotaka Watada, Andrew Cooper, Peter Fenici, Niklas Hammar, Jesús Medina, Mikhail Kosiborod, the DISCOVER investigators
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 5, Iss 2, Pp n/a-n/a (2022)
Abstract Background The key goals of management in patients with type 2 diabetes (T2D) are to prolong life and improve quality of life. Micro‐ and macrovascular complications of T2D not only increase the risk of morbidity and mortality, but cross
Externí odkaz:
https://doaj.org/article/9ed190f5132449e2ae21f646b8e71319
Publikováno v:
Journal of the Pakistan Medical Association, Vol 71, Iss 8 (2021)
Published in August 2021
Externí odkaz:
https://doaj.org/article/514a625e223c4c3685f6fae1eec230c5
Autor:
Jesús Medina, Peter Fenici, Linong Ji, Fengming Tang, Hirotaka Watada, Antonio Nicolucci, Wolfgang Rathmann, Suzanne V Arnold, Iichiro Shimomura, Mikhail Kosiborod, Hungta Chen, Andrew Cooper, Brenda Bongaerts, Bernard H Charbonnel, Marilia Gomes, Marina Shestakova
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 9, Iss 1 (2021)
Introduction Although individualized target glycated hemoglobin (HbA1c) levels are recommended in older people with type 2 diabetes, studies report high levels of potential overtreatment. We aimed to investigate the proportion of older patients (aged
Externí odkaz:
https://doaj.org/article/43da6cdaaf924397ad77881be216d19f
Autor:
Peter Fenici, Niklas Hammar, Linong Ji, Fengming Tang, Hirotaka Watada, Antonio Nicolucci, Wolfgang Rathmann, Iichiro Shimomura, Marilia B Gomes, Mikhail Kosiborod, Stuart Pocock, Marina V Shestakova, Hungta Chen, Javier Cid-Ruzafa
Publikováno v:
BMJ Open, Vol 10, Iss 8 (2020)
Objectives To evaluate the extent to which patients with type 2 diabetes discontinue metformin therapy when initiating second-line treatment and factors associated with metformin discontinuation, using baseline data from the DISCOVER study programme.
Externí odkaz:
https://doaj.org/article/3fa27abaed344ef894964068e1189e22
Autor:
Mikhail Kosiborod, Marilia B. Gomes, Antonio Nicolucci, Stuart Pocock, Wolfgang Rathmann, Marina V. Shestakova, Hirotaka Watada, Iichiro Shimomura, Hungta Chen, Javier Cid-Ruzafa, Peter Fenici, Niklas Hammar, Filip Surmont, Fengming Tang, Kamlesh Khunti, for The DISCOVER investigators
Publikováno v:
Cardiovascular Diabetology, Vol 17, Iss 1, Pp 1-13 (2018)
Abstract Background The global prevalence of type 2 diabetes-related complications is not well described. We assessed prevalence of vascular complications at baseline in DISCOVER (NCT02322762; NCT02226822), a global, prospective, observational study
Externí odkaz:
https://doaj.org/article/fbc8805de658404293adbd290ad8feef